These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1005 related items for PubMed ID: 18163505

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.
    Schou M, Gustafsson F, Kistorp CN, Corell P, Kjaer A, Hildebrandt PR.
    Am J Cardiol; 2007 Nov 15; 100(10):1571-6. PubMed ID: 17996522
    [Abstract] [Full Text] [Related]

  • 23. Admission NT-proBNP levels, renal insufficiency and age as predictors of mortality in elderly patients hospitalized for acute dyspnea.
    Reny JL, Millot O, Vanderecamer T, Vergnes C, Barazer I, Sedighian S, Berdagué P.
    Eur J Intern Med; 2009 Jan 15; 20(1):14-9. PubMed ID: 19237086
    [Abstract] [Full Text] [Related]

  • 24. Predictive value of NT-proBNP in vascular surgery patients with COPD and normal left ventricular systolic function.
    van Gestel YR, Goei D, Hoeks SE, Sin DD, Flu WJ, Stam H, Mertens FW, Bax JJ, van Domburg RT, Poldermans D.
    COPD; 2010 Feb 15; 7(1):70-5. PubMed ID: 20214466
    [Abstract] [Full Text] [Related]

  • 25. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH, Lu TM, Wu TC, Lin FY, Chen YH, Chen JW, Lin SJ.
    Coron Artery Dis; 2008 May 15; 19(3):187-93. PubMed ID: 18418236
    [Abstract] [Full Text] [Related]

  • 26. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M, Bazzino O, Navarro Estrada JL, Fuselli JJ, Botto F, Perez de Arenaza D, Möllmann H, Nef HN, Elsässer A, Hamm CW.
    J Am Coll Cardiol; 2008 Mar 25; 51(12):1188-95. PubMed ID: 18355657
    [Abstract] [Full Text] [Related]

  • 27. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.
    Chung L, Fairchild RM, Furst DE, Li S, Alkassab F, Bolster MB, Csuka ME, Derk CT, Domsic RT, Fischer A, Frech TM, Gomberg-Maitland M, Gordon JK, Hinchcliff M, Hsu V, Hummers LK, Khanna D, Medsger TAJ, Molitor JA, Preston IR, Schiopu E, Shapiro L, Hant F, Silver R, Simms R, Varga J, Steen VD, Zamanian RT.
    Clin Exp Rheumatol; 2017 Mar 25; 35 Suppl 106(4):106-113. PubMed ID: 27908301
    [Abstract] [Full Text] [Related]

  • 28. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.
    Perna ER, Macin SM, Cimbaro Canella JP, Szyszko A, Franciosi V, Vargas Morales W, Bayol AP, Kriskovich JO, Medina F, Gonzalez Arjol B, Brizuela M.
    J Heart Lung Transplant; 2006 Oct 25; 25(10):1230-40. PubMed ID: 17045936
    [Abstract] [Full Text] [Related]

  • 29. Amino terminal B-type natriuretic peptide, renal function, and prognosis in acute heart failure: a hospital cohort study.
    Pimenta JM, Almeida R, Araújo JP, Azevedo A, Friões F, Rocha-Gonçalves F, Ferreira A, Bettencourt P.
    J Card Fail; 2007 May 25; 13(4):275-80. PubMed ID: 17517347
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
    Behnes M, Brueckmann M, Ahmad-Nejad P, Lang S, Wolpert C, Elmas E, Kaelsch T, Gruettner J, Weiss C, Borggrefe M, Neumaier M.
    Int J Cardiol; 2009 Jun 26; 135(2):165-74. PubMed ID: 18603317
    [Abstract] [Full Text] [Related]

  • 32. Cardiac biomarkers for risk stratification in non-massive pulmonary embolism: a multicenter prospective study.
    Vuilleumier N, Le Gal G, Verschuren F, Perrier A, Bounameaux H, Turck N, Sanchez JC, Mensi N, Perneger T, Hochstrasser D, Righini M.
    J Thromb Haemost; 2009 Mar 26; 7(3):391-8. PubMed ID: 19087222
    [Abstract] [Full Text] [Related]

  • 33. Glomerular filtration rate and N-terminal pro-brain natriuretic peptide as predictors of cardiovascular mortality in vascular patients.
    Shadman R, Allison MA, Criqui MH.
    J Am Coll Cardiol; 2007 Jun 05; 49(22):2172-81. PubMed ID: 17543637
    [Abstract] [Full Text] [Related]

  • 34. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
    Rothenbacher D, Koenig W, Brenner H.
    Arch Intern Med; 2007 Jun 05; 166(22):2455-60. PubMed ID: 17159010
    [Abstract] [Full Text] [Related]

  • 35. Aminoterminal B-type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications?
    Pimenta J, Sampaio F, Martins P, Carvalho B, Rocha-Gonçalves F, Ferreira A, Bettencourt P.
    Nephron Clin Pract; 2009 Jun 05; 111(3):c182-8. PubMed ID: 19194108
    [Abstract] [Full Text] [Related]

  • 36. Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation.
    Weber M, Hausen M, Arnold R, Moellmann H, Nef H, Elsaesser A, Mitrovic V, Hamm C.
    Int J Cardiol; 2008 Jul 21; 127(3):321-7. PubMed ID: 18055041
    [Abstract] [Full Text] [Related]

  • 37. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M, Bozkurt A, Yildiray-Sahin D, Unal I, Acartürk E.
    Cardiol J; 2009 Jul 21; 16(1):43-9. PubMed ID: 19130415
    [Abstract] [Full Text] [Related]

  • 38. Use of N-terminal pro-brain natriuretic peptide to detect acute cardiac dysfunction during weaning failure in difficult-to-wean patients with chronic obstructive pulmonary disease.
    Grasso S, Leone A, De Michele M, Anaclerio R, Cafarelli A, Ancona G, Stripoli T, Bruno F, Pugliese P, Dambrosio M, Dalfino L, Di Serio F, Fiore T.
    Crit Care Med; 2007 Jan 21; 35(1):96-105. PubMed ID: 17095948
    [Abstract] [Full Text] [Related]

  • 39. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S, Boronat-Garcia M, Albaladejo-Otón MD, Pastor P, Garrido IP, Pastor-Pérez FJ, Martínez-Hernández P, Valdés M, Pascual-Figal DA.
    Am J Cardiol; 2009 Jun 15; 103(12):1753-9. PubMed ID: 19539088
    [Abstract] [Full Text] [Related]

  • 40. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
    Kwon TG, Bae JH, Jeong MH, Kim YJ, Hur SH, Seong IW, Cho MC, Seung KB, Jang YS, Park SJ, Korea Acute Myocardial Infarction Registry Investigators.
    Int J Cardiol; 2009 Apr 03; 133(2):173-8. PubMed ID: 18281115
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.